Ken Berlin

Mr. Kenneth A. Berlin is a President, Chief Executive Officer & Director at Old Ayala, Inc., a Chief Executive Officer & Director at Biosight Therapeutics, Inc., a President, Chief Executive Officer & Director at Ayala Pharmaceuticals, Inc. and a President at Rosetta Genomics, Inc. He is on the Board of Directors at Old Ayala, Inc., Biosight Therapeutics, Inc. and Ayala Pharmaceuticals, Inc. Mr. Berlin was previously employed as a President, Chief Executive Officer & Director by Advaxis, Inc., a President & Chief Executive Officer by Rosetta Genomics Ltd., a General Manager by Veridex LLC, a Vice President-Worldwide Franchise Development by Ortho-Clinical Diagnostics, Inc., a Vice President-Franchise Development by Johnson & Johnson, and a General Manager-Worldwide by Newell Brands, Inc. He received his undergraduate degree from Princeton University and a graduate degree from UCLA School of Law.